When big infrastructure projects spring up, one crucial law — the National Environmental Policy Act — has for decades been a ...

Tevogen ('Tevogen Bio Holdings Inc.” or 'Company”) (Nasdaq: TVGN), today welcomes the White House’s release of 'Winning the ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...

Investing.com -- PTC (NASDAQ: PTC) Therapeutics (NASDAQ: PTCT) stock rose 9% after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug SEPHIENCE (sepiapterin) ...

The global In Vitro Fertilization Market is valued at USD 28.12 Billion in 2024 and is projected to reach a value of USD 63.7 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 7.75% between ...

Mrs. Doubtfire’ star says it would be ‘so cool’ to revive Robin Williams’ iconic voice with AI for new projects ...

Incretin receptor agonists, including GLP-1 and dual GIP/GLP-1 agents, have revolutionized the treatment landscape for type 2 diabetes and obesity by ...

Organ transplantation remains the most effective treatment for end-stage diseases. However, persistent challenges such as organ shortage, immune rejection, ...

Verona Pharma plc (NASDAQ:VRNA) is one of the best multibagger stocks according to hedge funds. On July 9, 2025, Merck & Co.

An announcement from PTC Therapeutics ( ($PTCT) ) is now available. On July 28, 2025, PTC Therapeutics announced that the FDA approved Sephience™ ...

In this video interview, Michael Miller, chief operating officer at Quanterix, discusses how the use of biomarkers is ...